Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/INNATE-PHARMA-35620/news/Innate-Pharma-prasentiert-positive-Ergebnisse-der-Phase-2-Studie-TELLOMAK-mit-Lacutamab-bei-Patient-45539336/?utm_source=whatsapp&utm_medium=social&utm_campaign=share